Clinical trial
Phase I Study of Aprotinin in Advanced Breast Cancer
NCT00354900
Study timeline
Study start (unknown)2006-07-01Date precision: month
Registry last updated2009-08-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Breast Cancerunresolved
Interventions
AprotininDRUG · verified · RxNorm: aprotinin
Sponsors & collaborators
Dartmouth-Hitchcock Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00354900 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.